2,6-Bis((3,4-dihydroxyphenyl)-methylene)cyclohexanone (BDHPC)-Induced Apoptosis and p53-Independent Growth Inhibition: Synergism with Genistein
- 20 October 1997
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 239 (2), 467-472
- https://doi.org/10.1006/bbrc.1997.7495
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- ERβ: Identification and characterization of a novel human estrogen receptorFEBS Letters, 1996
- p53 in signaling checkpoint arrest or apoptosisCurrent Opinion in Genetics & Development, 1996
- Wild-type p53 is a cell cycle checkpoint determinant following irradiation.Proceedings of the National Academy of Sciences of the United States of America, 1992
- Preliminary characterization and partial purification of rat uterine nuclear type II binding sitesBiochemical and Biophysical Research Communications, 1991
- Estrogen regulation of methyl p-hydroxyphenyllactate hydrolysis: Correlation with estrogen stimulation of rat uterine growthJournal of Steroid Biochemistry, 1989
- Heterogeneity of [3H]estradiol binding sites in the rat prostate: Properties and distribution of type I and type II sitesThe Journal of Steroid Biochemistry and Molecular Biology, 1989
- Heterogeneity of estrogen binding sites in mammary tumorsBreast Cancer Research and Treatment, 1983
- Heterogeneity of Nuclear Estrogen-Binding Sites in the Rat Uterus: A Simple Method for the Quantitation of Type I and Type II Sites by [3H]Estradiol Exchange*Endocrinology, 1981
- Progesterone and dexamethasone antagonism of uterine growth: A role for a second nuclear binding site for estradiol in estrogen actionThe Journal of Steroid Biochemistry and Molecular Biology, 1981
- Two Binding Sites for Estradiol in Rat Uterine Nuclei: Relationship to Uterotropic Response*Endocrinology, 1979